Penelope Drake

Penelope Drake

Company: Catalent

Job title: Head of R&D, Bioconjugates

Seminars:

Live Discussion & Question Time 2:30 pm

Read more

day: Track B - Day 1 PM

Catalent’s SMARTag® Technology: Differentiated Solutions for Optimal ADCs  1:50 pm

SMARTag is a clinical-stage ADC technology featuring site-specific conjugation with multiple linker and warhead options. 6 CRs and 2 PRs among 22 patients were achieved by TRPH-222, a CD22-targeted SMARTag conjugate, in the dose-escalation stage of a Phase 1 trial for R/R B-cell lymphoma. We are using new linkers to achieve proprietary high DAR ADCs…Read more

day: Track B - Day 1 PM

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.